In CML, CBL is heavily phosphorylated by BCR-ABL and binds tyrosine phosphorylated CRK SH2 domain [119], which is associated with formation of a RAC1-activating complex [120, 121]. Here, CRK is linked to chronic myelogenous leukemia, BCR-ABL1 positive.